Invivyd at the Ready for Upcoming Respiratory Virus Season with PEMGARDA™ ( pemivibart ) to Help Protect Vulnerable Immunocompromised Persons from COVID-19

a week ago

WALTHAM, Mass., Sept. 12, 2024 ( GLOBE NEWSWIRE ) -- Invivyd, Inc. ( Nasdaq: IVVD ) , a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced a business readiness update in response to a recent increase in COVID-19 cases nationwide.

Ticker	Sentiment	Impact
IVVD	Neutral	21 %